本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Ocular Therapeutix

7.00
-0.3900-5.28%
盤後7.000.00000.00%17:01 EDT
成交量:179.01萬
成交額:1,281.14萬
市值:11.15億
市盈率:-6.09
高:7.56
開:7.47
低:6.96
收:7.39
資料載入中...
2025/05/05

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/05/05

重要事件披露

Form 8-K - Current report
2025/03/03

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/03/03

重要事件披露

Form 8-K - Current report
2025/02/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/14

重要事件披露

Form 8-K - Current report
2025/02/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/31

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/25

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/25

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/25

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/25

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/25

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/14

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/11/14

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]